Johnson & Johnson (JNJ) Q2 2021 Earnings call
Johnson & Johnson (NYSE: JNJ) Q2 2021 Earnings Conference
Market News
Johnson & Johnson (JNJ) Q1 2021 Earnings Call
Johnson & Johnson (NYSE: JNJ) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Christopher DelOrefice — Vice President of Investor Relations Joseph J. Wolk — Executive Vice President and Chief…
Johnson & Johnson (JNJ) Q1 2021 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Christopher DelOrefice — Vice President of Investor Relations Joseph J. Wolk — Executive Vice…
AlphaGraphs
Johnson & Johnson (JNJ) reports Q1 2021 earnings
Johnson & Johnson (NYSE: JNJ) reported first-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue of $22.3 billion,…
Johnson & Johnson (JNJ) Q1 2021 Earnings Call
Johnson & Johnson (NYSE: JNJ) Q1 2021 Earnings Conference
Market News
Johnson & Johnson’s (JNJ) single-dose vaccine is effective but lags behind rivals
Johnson & Johnson (NYSE: JNJ) is the latest pharma company to provide results from the trial of its COVID-19 vaccine candidate. The company reported that its…
Johnson & Johnson (JNJ) Q4 2020 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q4 2020 earnings call dated Jan. 26, 2021. Corporate Participants: Chris DelOrefice — Vice President, Investor Relations Alex Gorsky — Chairman of the Board…
Market News
Johnson & Johnson (JNJ): Strength in ecommerce drives growth in Consumer Health
Shares of Johnson & Johnson (NYSE: JNJ) gained nearly 3% in morning trade on Tuesday after the company reported fourth quarter 2020 earnings results that…
AlphaGraphs
Johnson & Johnson (JNJ) beats market estimates in Q4
Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2020 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported fourth-quarter revenue of $22.5…
Market News
Johnson & Johnson’s (JNJ) COVID-19 vaccine would have an edge over others without this glitch
Johnson & Johnson (NYSE: JNJ) saw its shares climb 2% on Thursday after the company reported positive results from the early-stage trials of its COVID-19…